97国际
中
EN
LINK
NMPA
MUYA AGRI-TECH
LONGJIN BIO-TECH
Shanghai Rouyishi BIO-TECH
YUNNAN MPA
About Longjin
Product & business
Science & Technology
News
Careers
Longjin Profile
Longjin History
Longjin's Mission &Vision
Longjin's Core Vlues
Responsibilities
Recognitions
Founder's Message
Medicines
HEMP
Natural?Plant?Extracts
Prospective Study
R&D Achievements
Smart Manufacturing
Whole Industry Chain
Notifications
Company News
LONGJIN IN Media
Longjin Culture
Grow With Us
Work At Longjin
Job Openings
NEWS
通知公示
97国际动态
媒体报道
注射用灯盏花素治疗急性脑梗死和冠心病心绞痛的临床综合评价
DATE:2023.11.22 SOURCE:原创 VIEW:3910
问题:注射用灯盏花素治疗急性脑梗死和冠心病心绞痛的临床综合评价
刘 毅,,,,,,耿洪娇,,,,,,崔 鑫,,,,,,张旭明
*
,,,,,,谢雁鸣
*
中国中医科学院 中医临床基础医学研究所,,,,,,北京
100700
PREV:
注射用灯盏花素治疗脑梗死的药物经济学评价
NEXT:
注射用灯盏花素临床应用专家共识宣布
IR-app
Wechat
TERMS OF USE
Copyright Statement
Privacy Policy
Contact us
Site Navigation
ADR Reports
Copyright @ KumMing Longjin Pharmaceutical Co., Ltd. All Rights Reserved
滇公网安备 53019002000234号
互联网药品信息服务允许证:(滇)-非谋划性-2020-0014? ?滇ICP备13000870号-1
Technical Support:AYKJ
【网站地图】
【sitemap】